The choroid plexus (ChP) is a highly vascularized tissue found in the brain ventricles, with an 18 apical epithelial cell layer surrounding fenestrated capillaries. It is responsible for the production of most 19 of the cerebrospinal fluid (CSF) in the ventricular system, subarachnoid space, and central canal of the 20 spinal cord, while also constituting the blood-CSF barrier (BCSFB). In addition, epithelial cells of the 21 choroid plexus (EChP) synthesize neurotrophic factors and other signaling molecules that are released 22 into the CSF. Here we show that insulin is produced in EChP of mice and humans, and its expression and 23 release are regulated by serotonin. Insulin mRNA and immune-reactive protein, including C-peptide, are 24 present in EChP, as detected by several experimental approaches, and in much higher levels than any 25 other brain region and non-pancreatic peripheral tissues. Moreover, insulin is produced in primary 26 cultured mouse EChP, and its release, albeit Ca 2+ -sensitive, is not regulated by glucose. Instead, 27 activation of the 5HT2C receptor by serotonin treatment led to activation of IP3-sensitive channels and 28 Ca 2+ mobilization from intracellular storage, leading to insulin secretion. In vivo depletion of brain 29 serotonin in the dorsal raphe nucleus negatively affected insulin expression in the ChP, suggesting an 30 endogenous modulation of ChP insulin by serotonin. Therefore, for the first time to our knowledge, here 31 we show that insulin is produced by EChP in the brain, and its release is modulated at least by serotonin, 32 and not glucose. 33
Introduction 35
Exploring the role(s) of insulin and its downstream signaling in brain is an ongoing area of 36 research because of its reported involvement in brain function in aging and disease. There is substantial 37 epidemiological data supporting a role for insulin resistance in Alzheimer's disease and reduced life span 38 in humans (1-5). However, there is also substantial data for reduced insulin and IGF1 signaling in 39 preventing neurodegeneration in mice (6,7) and in extending life span in worms, flies, mice and maybe 40 even in higher-order mammals (8-12). These data clearly seem in direct conflict since, in both cases, 41 there is reduced downstream insulin signaling. However, it is entirely possible, as already suggested 42 (13) , that there are differences in total organismal metabolic outcome between insulin resistance in 43 insulin-sensitive tissues (liver, fat and muscle) that are reliant on insulin for glucose uptake, and 44 decreased insulin signaling in so-called insulin insensitive cells, such as neurons, as it could occur due to 45 reductions in the availability of the insulin molecule itself within the brain. And it is also possible to have 46 both scenarios present in the same organism. Indeed, intranasal insulin is now being investigated in 47 humans as a way to increase the availability of insulin to brain areas and study its impact on cognition 48
and Aβ plaque deposition in humans with insulin resistance (14) . For all these reasons it seems 49 important to clarify the source of insulin in the brain. 50 hippocampus, and in the olfactory bulb (30), whereas a broader insulin expression in the brain, 67 encompassing hippocampus, striatum, hypothalamus, entorhinal and prefrontal cortices, and low levels 68 in olfactory bulbs, was later described (31). More recently, insulin secretion was also reported in 69 cultured astrocytes (32), adding to the controversy. 70
In order to identify possible sites of insulin production in the brain, we first carried out 71 fluorescent in situ hybridization (FISH) for insulin expression across slices of whole mouse brain. The 72 one structure that gave a clear, unequivocal signal over multiple brain sections was the choroid plexus 73 (ChP); all other brain areas gave either a weak, by comparison to ChP, or no signal. We therefore 74 concentrated further attention on this structure. Here we describe the presence not only of insulin 75 mRNA but also the protein itself in the epithelial layer of the choroid plexus of mice and humans, as well 76 as proteins associated with insulin processing and secretion using a range of diverse investigational 77 methods. Insulin and C-peptide are also clearly present in cultured primary epithelial cells of the 78 choroid plexus (EChP). We compared insulin expression and related proteins across the ChP of the 79 lateral and fourth ventricles, and we further investigated the modulation of insulin expression and the 80 underlying molecular mechanisms and intracellular pathways necessary for its secretion using in vitro 81 and in vivo approaches. 82
Results

83
ChP expresses and produces insulin, but not islet amyloid polypeptide (IAPP) 84 Rodents such as mice and rats have 2 insulin genes: Ins1 expression is thought to be restricted 85 to pancreatic β-cells in islets of Langerhans, whereas Ins2, the ancestral gene, possibly has a broader 86 tissue expression pattern. We have previously reported that Ins2 is expressed and mature insulin is 87 synthesized in taste cells within taste buds (21). Fluorescent in situ hybridization (FISH) for Ins2 RNA in 88 brain sections reveals a clear, strong signal only in the ChP (figure 1A) and colocalized with ChP marker 89 transthyretin (Ttr), while Ins1 was detected at low levels ( figure 1B ). Insulin is transcribed as a 90 preproprotein, a single polypeptide composed of a signal peptide, β chain, C-peptide, and α chain. The 91 signal peptide is needed for translocation to and across the endoplasmic reticulum (ER), where it is 92 cleaved from the preproinsulin molecule. Proinsulin exits the ER and is delivered to the Golgi apparatus 93 for packaging in secretory vesicles. With the maturation and acidification of these vesicles, proinsulin is 94 cleaved by proconvertases, freeing the C-peptide (33). Insulin staining in ChP from perfused animals 95 shows a pattern congruent with insulin secretion into the CSF (figure 1C): the apical layer of the ChP is 96 stained positive, while the stroma, which is highly vascularized, is absent of signal. C-peptide 97 immunofluorescence signal is also present in the ChP, an additional confirmation that insulin is being 98 produced locally ( figure 1C ). IHC of human choroid plexus sections for insulin and C-peptide are also 99 consistent with this finding (figures 1D and 1E). C-peptide clearly has a perinuclear and apical signal 100 (figure 1E) within ChP and IHC of insulin has an apical staining (figure 1D). Specificity of our detection 101 methods are shown in Supplemental Figure S1 . 102 Compared to islets isolated from mouse pancreata, the profile of Ins2 expression in the ChP is 103 vastly different. The Ins2 gene has 3 known splicing variants (34) (figure 2A), and RT-qPCR analysis for 104 each specific variant reveals differential isoform expression patterns between the ChP and islets. The 105 transcript variant 2 of the Ins2 RNA (hereafter referred as Ins2-2) is the main splicing variant found in 106 islets, while it has low expression in the ChP ( figure 2B ). On the other hand, variants 1 and 3 (Ins2-1 and 107
Ins2-3, respectively) are the major isoforms expressed in the ChP, while their relative levels in the islets 108 are approximately 50 times lower than Ins2-2 ( figure 2B ). Expanding the comparison of Ins2 expression 109 to other brain regions, we find that Ins2 mRNA variants have higher levels of expression in the ChP than 110 in any other brain area, with the exception of the olfactory bulb, in which Ins2-2 and Ins2-3 expression 111 levels are similar with ChP (figure 2C-E). All results are summarized in table 1. 112
The ChP of the lateral and third ventricles develop independently from that of the 4 th ventricle; 113 however, the ventricles are connected through the aqueduct of Sylvius, which does not contain ChP. In 114 attempting to further characterize insulin expression in the ChP, we compared the expression levels of 115 Ins1 and Ins2 between the ChP of the fore (lateral ventricles) and hindbrain (4 th ventricle) ( figure 2G ). 116
Interestingly, expression levels of Ins1 and Ins2-1 and 2-3 are consistently higher in the hindbrain ChP. 117
We also investigated the expression of the enzymes necessary for the conversion of preproinsulin (the 118 translated product of the insulin gene) into the active mature insulin. The genes of both proconvertases 119 1/3 (Pcsk1) and 2 (Pcsk2) are expressed in the ChPs, with higher levels of Pcsk2 expression in the 4 th V 120
ChP ( figure 2F ). We could not detect islet amyloid polypeptide (IAPP), which is stored and co-released 121 with insulin in pancreatic β-cells, by FISH, PCR, or immunostaining in either ChP or primary EChP cells 122 (data not shown). Increase in intracellular cAMP levels by acute forskolin treatment also did not change cytosolic Ca 2+ 147 (data not shown). Similarly, a GLP1 receptor agonist, exendin-4, had no effects on intracellular Ca 2+ 148 concentrations (Supplemental Figure S2A) . 149
Because the ChP has a high density of serotonin receptors (36), we investigated the EChP cells 150 response to serotonin. At a final concentration of 5 µM, serotonin induced an acute, 3-fold increase in 151 the fluorescence intensity (figure 4C, D) emitted by the Ca 2+ probe. Ca 2+ mobilization from intracellular 152 storages was confirmed using a Ca 2+ -free medium containing EGTA ( figure 4D ). Comparison of area 153 under the curve (AUC) between the two groups showed no statistical difference, suggesting that the 154 entirety of the iCa 2+ increase elicited by serotonin comes from iCa 2+ storage sites ( figure 4D ). 155
Involvement of IP3 receptors (IP3R) in this serotonin-dependent Ca 2+ increase was assessed 156 using the IP3 receptor blocker 2APB at a final concentration of 150 µM. Under such conditions, 157 serotonin completely failed to elicit any iCa 2+ increase ( figure 4E ). Similarly, no Ca 2+ mobilization was 158 seen when the serotonin receptor HTR2C, a Gq/11-coupled metabotropic receptor, was antagonized with 159 RS102221 (50 µM) when cells were stimulated with serotonin ( figure 4E ). We also looked for the 160 possible involvement of ryanodine receptors (RYRs) in this phenomenon by blocking RYRs with 161 dantrolene (10 µM) and concluded they do not play any role in the calcium mobilization induced by 162 serotonin (Supplemental Figure S2A ). 163
164
Insulin produced in the ChP is actively secreted 165 We treated primary EChP cells for 24 hours with serotonin (5 µM) and/or IP3R antagonist 2APB 166 (150 µM) and determined insulin concentration in the supernatant using an ultra-sensitive ELISA. 167 Supernatant from untreated cultures had a mean insulin concentration of 0.025 µg/L, and serotonin 168 treatment induced a statistically significant 42% increase in insulin concentration (figure 5A), which was 169 completely prevented by 2APB co-treatment. Interestingly, 2APB treatment by itself led to a 35% 170 reduction in insulin levels in the supernatant, further suggesting a role for IP3Rs in insulin secretion in 171 these cells ( figure 5A ). In addition to insulin secretion stimulation, ECHP cells treated with serotonin also 172 exhibited higher levels of Ins1 and Ins2 mRNA after 4 hours of stimulus, as evaluated by RT-qPCR (figure 173 5B). Protein content, as evaluated by Western Blotting, of cells treated with serotonin also had higher 174 levels of vesicular proteins associated with insulin secretion in β-cells ( figure 5C ). Even though acute (4-175 hours) treatment with exendin-4 (10 nM) did not have any effect on insulin secretion (Supplemental 176 Figure S2B ), it had a positive effect on Ins2 expression levels (Supplemental Figure S2C ). basal (blood vessel-facing) membranes. In order to further understand the interplay between serotonin 179 and ChP insulin secretion, permeable membrane support inserts were used as substrate for primary 180 EChP cells. Once confluent, these cells form tight junctions, as shown by ZO-1 staining (figure 5E), 181 effectively isolating two compartments in the cell culture system. Complete confluency was confirmed 182 using a voltohmmeter to assess the transepithelial electrical resistance between the two compartments, 183 and readings between 100-150 Ωcm 2 were considered compatible with confluent cultures. In Insulin signaling in the brain is implicated in healthy cognitive function and its decline with aging 216 and neurodegeneration. Although it has been long hypothesized that insulin is able to cross the blood 217 brain barrier (BBB) through a saturable transport system, said mechanism is limited and inefficient. In 218 that sense, local insulin production within the brain tissue seems to be a possibility, but scientific reports 219 addressing this question are still surrounded by controversy. As such, conclusive identification of an 220 insulin source in the brain would not only allow us to better understand the importance of insulin in 221 brain physiology, but it could also point to a new therapeutic target for dementia and age-related 222 cognitive disorders. 223
Using fluorescent in situ hybridization for Ins2 mRNA in sagittal sections of mouse brains, we 224
show that brain insulin mRNA is predominantly expressed not in the brain parenchyma, but in the 225 epithelial layer of the choroid plexus, where we also detected expression of enzymes needed for 226 maturation of preproinsulin into its mature, bioactive form. In agreement with our findings, Ins2 227 expression by epithelial cells of the choroid plexus was also detected by single-cell RNA sequencing, as 228 described recently by Dani et al (37). 229
We detected immunoreactive insulin and C-Peptide in the ChP of mice and humans, as well as in 230 primary cultured mouse choroid plexus epithelial cells (EChP). To our knowledge, this is the first report 231 of insulin production in ChP. Previous work with insulin reporter genetic models demonstrated Ins2 232 expression in murine ChP (38,39), but no Ins2 promoter activity in any other brain structure. These 233 models, however, failed to detect insulin mRNA or its corresponding protein. Conversely, several studies 234 using mice with Cre expression driven by the rat insulin promoter (RIP-Cre) describe strong Cre 235 expression in hypothalamic neurons (40,41). However, RIP-Cre mice use a short portion (448 bp) of the 236 rat Ins2 gene promoter to drive Cre expression (42), which make them susceptible to ectopic expression 237 due to unspecific promoter activity. 238
Unlike β-cells, glucose stimulation did not influence insulin secretion in cultured EChP cells, 239 failing to elicit any iCa 2+ response. Indeed, ChP epithelial cells do not express Kir6.1 and Kir6.2, necessary 240 for the formation of the ATP-sensitive K + channel, nor do they contain voltage-gated Ca 2+ channels (43).
Instead, we found that activation of the serotonergic receptor 5HT2C causes iCa 2+ mobilization mediated 242 by IP3 receptors in the endoplasmic reticulum, ultimately culminating in insulin release. Also absent is 243 the islet amyloid polypeptide (IAPP), expressed and co-secreted with insulin in β-cells (44). Blood-244 derived IAPP can be found throughout the brain (45), and high-affinity IAPP binding sites are found in 245 circumventricular organs with leaky capillaries, such as the area postrema, nucleus of the solitary tract, 246 and hypothalamus (46). However, Li and colleagues reported IAPP mRNA and protein in hypothalamic 247 neurons, suggesting for the first time that IAPP is produced in the brain (47). Yet, using the same IAPP 248 antibody and qPCR primers, we could not detect either mRNA or immunoreactive IAPP in ChP of mice or 249
humans. 250
Another relevant difference between ChP and β-cell insulin production is the content of specific 251
Ins2 splicing variants. Mouse Ins2 gene splicing produces three variants, Ins2-1, Ins2-2, and Ins2-3 (34), 252 that encode the same preproinsulin protein coding region. However, they differ in their 5' untranslated 253 region (5'-UTR). While Ins2-2 is the predominant variant in pancreatic islets, Ins2-1 and Ins2-3 are the 254 predominant isoforms in EChP cells. The 5'-UTR of Ins2 splicing variants might be involved in differential 255 translation efficiency and subcellular localization of insulin in β-cells and ChP. Exploring these 256 differences might help us to better understand the role of ChP-derived insulin and the mechanisms 257 regulating its expression and production. 258
Even though the ChP has a high density of serotonergic receptors (48), of which 5HT2C is the 259 most abundant, serotonin effects on ChP activity is still largely debated. Intracerebroventricular 260 injection of serotonin seems to have a negative effect on CSF production (49), while at the same time 261 elevations in blood serotonin levels increase blood flow to the ChP (50). These seemingly paradoxical 262 findings indicate a disconnect between blood supply and metabolism of EChP cells. In fact, activation of 263 5HT2C in EChP cells has been associated with a decrease in carbonic anhydrase (51) and Na + /K + pump 264 (52) activities, leading to a negative effect on CSF formation in both cases. The epithelial layer of the ChP 265 and its associated vasculature are stimulated by cholinergic and adrenergic innervations (53), and 266 evidence in rats support the idea that serotonergic nerves may also be present in the ChP (54,55). 267
Another possible source might be serotonergic fibers and terminals located over the ependymal layer 268 lining the ventricles (56). These nerve terminals do not form classic synapses; instead they are thought 269 to release serotonin directly in the CSF (57), where it could diffuse and act on the nearby ChP. This 270 network of fibers, known as supra and subependymal plexus, is composed mainly of serotoninergic 271 nerve terminals originating from the Raphe nuclei in the brainstem (58).
We show that serotonergic neurons from the dorsal Raphe nucleus modulate insulin expression 273 in the ChP, and serotonin induces insulin release from the EChP cells. A relationship between serotonin 274
and insulin is already very well described in other systems. In pancreatic islets, for example, β-cell mass 275 and insulin release during pregnancy are reported to be regulated by serotonin (59,60). In the 276 hypothalamus, levels of extracellular serotonin and insulin increase after feeding (61,62) and, notably, 277 local induction of serotonergic activity in the ventromedial hypothalamus (VMH) / paraventricular 278 nucleus (PVN) acutely increases extracellular insulin in the hypothalamus, without any peripheral effect 279 on either circulating insulin or glucose levels (63). Furthermore, alloxan-induced diabetic rats treated 280 with fluoxetine, a serotonin reuptake inhibitor, had higher brain insulin levels than non-treated rats (64). 281
Taken together, these findings support our results showing that serotonin may be a regulator of insulin 282 levels in the brain and, more specifically, in the ChP. 283
The ChP also has a high density of insulin receptors (65), whose activity might have a positive 284 effect on CSF formation. Insulin induces Na + /H + exchanger (NHE) activity in different cells (66,67). In the 285
ChP, activation of NHE by insulin induces an increase in intracellular Na + concentrations, culminating in 286 higher K + and Clapical efflux, which is then followed by H2O diffusion (68). Additionally, insulin signaling 287 in the ChP is capable of inhibiting 5HT2C receptor signal transduction through a MAPK-dependent way 288 (69). As such, one possible explanation of our findings could be that an integrated negative feedback 289 loop exists, wherein the ChP responds to serotonergic stimulation by releasing insulin, which in turn acts 290 in an autocrine/paracrine way to terminate 5HT2C intracellular signaling. 291 For many years it has been thought that insulin receptors transport blood-derived insulin across 292 endothelial cells in brain capillaries. In the last few years, however, this idea has been challenged. Insulin 293 is found in the brain parenchyma even when insulin receptor is genetically nullified in brain endothelial 294 cells or when the insulin receptor is pharmacologically blocked (70,71), adding to the controversy 295 surrounding peripheral insulin penetrance into the CNS. The identification of a major insulin source 296 within the brain, as it seems to be the case for the ChP, points to a more promising target for 297 therapeutic manipulation of insulin delivery to the brain. 298
In conclusion, brain insulin is synthesized in EChP cells and is actively secreted in response to 299 increased iCa 2+ levels, such as occurs after activation of plasma membrane 5HT2C receptors, but not were ordered from ACD. Freshly dissected mouse brains were immediately embedded in OCT and snap 336 frozen in liquid nitrogen and stored at -80 0 C freezer in a sealing bag before use. Sections (15 µm) were 337 obtained in a cryostat microtome and then fixed with 10% neutral buffered formalin (NBF) right before 338 hybridization and staining steps. Pretreatment of brain sections, probe reactions, and labeling were 339 performed according to RNAscope Multiplex Fluorescent Detection Kit v2 protocol, as previously 340 described (74). The negative control probe was a universal control probe targeting bacterial Dapb gene 341 using PicoPure RNA isolation kit (Thermo Fisher). RNA quality and purity were assessed in a NanoDrop 348 spectrophotometer (Thermo Fisher) and Bioanalyzer RNA 6000 nanochip (Agilent). Up to 2 µg of total 349 RNA were reverse transcribed into cDNA using qScript XLT cDNA SuperMix (QuantaBio). Resulting cDNA 350 was diluted (2.5-50 times) according to target abundance. Duplex qPCR assays were performed on 351 technical duplicates using a FAM-labeled target probe (Table 2) Immunohistochemistry and Immunofluorescence 363 For brain sections, C57BL/6J male mice were transcardiacally perfused with cold PBS followed by 364 cold PFA. Brains were removed and post-fixed in PFA for 4 additional hours, after which they were 365 maintained in PBS. Whole brains were dehydrated, paraffin embedded, and coronally sectioned (10 µm). Slides were deparaffinized in xylene, and sections rehydrated in successive incubations with 367 decreasing ethanol concentration. Heat-induced epitope retrieval was performed by placing the slides in 368 citrate buffer (pH = 7.0) and heating them to sub-boiling temperatures for 10 minutes in a microwave. 369
Sections used for DAB staining were then treated with hydrogen peroxide in order to block endogenous 370 peroxidase activity. All slides were incubated in a blocking solution consisted of 10% normal donkey 371 serum in PBS, and primary antibody incubation performed overnight at 4 o C. After washes, sections were 372 incubated in their respective secondary antibody solutions. Immunohistochemistry (IHC) staining was 373 amplified using the biotin-avidin system (Vector Laboratories) and then developed with a DAB and 374 hydrogen peroxide kit (Vector Laboratories). For immunofluorescence (IF), we used AlexaFluor-375 conjugated secondary antibodies (Thermo Fisher). The complete list of primary antibodies used for 376 immunohistochemistry/immunofluorescence can be found in Table 3 . Antibody against amylin (IAPP), 377 originally developed by Amylin Pharmaceuticals, was a gift from Dr. James Trevaskis (Gilead Sciences, 378 San Francisco). IHC pictures were taken in an Olympus IX51 microscope, and IF images were acquires 379 using a Zeiss 880 LSM confocal microscope. For IF of EChP, cells were fixed for 15 minutes in methanol 380 100%, permeabilized with PBS + 0.3% Triton-X, and blocked and incubated in antibody solutions as 381 
